Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Clinical and experimental hypertension • 2020 | View Paper
“2-(Hydroxymethyl)-N-[4-(methylsulfonyl)phenyl]-2′-(trifluoromethyl)biphenyl-4-carboxamide, SPI, and EPL elevated serum levels of potassium significantly in potassium-loaded rats at doses that increased MR inhibitory activity.”